Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.
about
Short-duration therapy for hepatitis C: suitable for all?Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection.Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis C.Hepatitis C virus RNA levels during initial induction or standard interferon therapy: influence of continued treatment on sustained response.Combination therapy for the treatment of hepatitis C in the veteran population: higher than expected rates of therapy discontinuation.Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial.A randomized controlled trial of amantadine plus interferon-alpha2a vs. interferon-alpha2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha2a monotherapy.
P2860
Q36768397-6DA314CD-A174-4704-AE79-0BBA8449CCD3Q42982615-C9C673BB-972D-47D8-A207-B59C7348180EQ42988882-0BC8ECAD-EF27-43E3-B480-F39EE5C3BBA4Q42990123-8FAAEA06-8250-4856-93E2-C88094200DBDQ43046523-84495A05-03BA-4291-83F3-0A61F299D449Q43048580-33A7FFAB-EB83-4AEF-8F5B-6435B498E275Q44330573-AD0ECA46-B509-4849-80DA-38A4064434CAQ44665741-E6FE1BFB-B297-4886-ACCC-73B40817A124Q48036349-322671C1-6D67-4E96-BD14-91F773E5123C
P2860
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Early viral clearance and sust ...... igh-dose interferon induction.
@en
Early viral clearance and sust ...... igh-dose interferon induction.
@nl
type
label
Early viral clearance and sust ...... igh-dose interferon induction.
@en
Early viral clearance and sust ...... igh-dose interferon induction.
@nl
prefLabel
Early viral clearance and sust ...... igh-dose interferon induction.
@en
Early viral clearance and sust ...... igh-dose interferon induction.
@nl
P2093
P2860
P50
P1476
Early viral clearance and sust ...... high-dose interferon induction
@en
P2093
P2860
P304
P356
10.1046/J.1365-2893.2002.00370.X
P577
2002-09-01T00:00:00Z